MX2009002787A - Composiciones y métodos para prevenir el cáncer con cupredoxinas. - Google Patents
Composiciones y métodos para prevenir el cáncer con cupredoxinas.Info
- Publication number
- MX2009002787A MX2009002787A MX2009002787A MX2009002787A MX2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A MX 2009002787 A MX2009002787 A MX 2009002787A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- cupredoxins
- tissues
- animals
- development
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 3
- 230000003902 lesion Effects 0.000 abstract 3
- 210000004962 mammalian cell Anatomy 0.000 abstract 3
- 108010007337 Azurin Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract 1
- 108010092351 cupredoxin Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84435806P | 2006-09-14 | 2006-09-14 | |
| PCT/US2007/078371 WO2008033987A2 (en) | 2006-09-14 | 2007-09-13 | Compositions and methods to prevent cancer with cupredoxins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009002787A true MX2009002787A (es) | 2009-08-27 |
Family
ID=39184582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009002787A MX2009002787A (es) | 2006-09-14 | 2007-09-13 | Composiciones y métodos para prevenir el cáncer con cupredoxinas. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2061498A4 (enExample) |
| JP (2) | JP2010503409A (enExample) |
| KR (1) | KR20090059152A (enExample) |
| CN (1) | CN101595124A (enExample) |
| AU (1) | AU2007296429A1 (enExample) |
| BR (1) | BRPI0714987A2 (enExample) |
| CA (1) | CA2663498A1 (enExample) |
| IL (1) | IL197602A0 (enExample) |
| MX (1) | MX2009002787A (enExample) |
| NO (1) | NO20091267L (enExample) |
| RU (1) | RU2009113812A (enExample) |
| SG (1) | SG174784A1 (enExample) |
| WO (1) | WO2008033987A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
| US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
| US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| US9598470B2 (en) * | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
| US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
| US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
| CN101437842A (zh) | 2004-10-07 | 2009-05-20 | 阿南达·查克拉博蒂 | 铜氧还蛋白衍生的转运制剂及其应用方法 |
| US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
| CA2615617A1 (en) | 2005-07-19 | 2007-01-25 | The Board Of Trustees Of The University Of Illinois | Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| CA2671492A1 (en) * | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| EP2114429A4 (en) * | 2007-02-08 | 2010-05-19 | Univ Illinois | COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES |
| CA3075836A1 (en) * | 2017-09-29 | 2019-04-04 | Oncgnostics Gmbh | Risk determination for neoplasia and cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
| CN1506375A (zh) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物 |
| CN101437842A (zh) * | 2004-10-07 | 2009-05-20 | 阿南达·查克拉博蒂 | 铜氧还蛋白衍生的转运制剂及其应用方法 |
| JP2008539795A (ja) * | 2005-05-20 | 2008-11-20 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンを用いたエフリン信号伝達に関する症状を治療するための組成物および方法 |
| EP1904081A4 (en) * | 2005-07-19 | 2008-12-03 | Univ Illinois | COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES |
-
2007
- 2007-09-13 CA CA002663498A patent/CA2663498A1/en not_active Abandoned
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/es not_active Application Discontinuation
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/ru unknown
- 2007-09-13 EP EP07842403A patent/EP2061498A4/en not_active Withdrawn
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/zh active Pending
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/en not_active Ceased
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/ko not_active Withdrawn
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/ja not_active Withdrawn
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/pt not_active Application Discontinuation
-
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/no not_active Application Discontinuation
-
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010503409A (ja) | 2010-02-04 |
| EP2061498A4 (en) | 2009-11-04 |
| RU2009113812A (ru) | 2010-10-20 |
| WO2008033987A3 (en) | 2009-04-30 |
| SG174784A1 (en) | 2011-10-28 |
| JP2014050390A (ja) | 2014-03-20 |
| WO2008033987A2 (en) | 2008-03-20 |
| CA2663498A1 (en) | 2008-03-20 |
| EP2061498A2 (en) | 2009-05-27 |
| AU2007296429A1 (en) | 2008-03-20 |
| KR20090059152A (ko) | 2009-06-10 |
| NO20091267L (no) | 2009-06-04 |
| IL197602A0 (en) | 2011-08-01 |
| CN101595124A (zh) | 2009-12-02 |
| BRPI0714987A2 (pt) | 2013-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009002787A (es) | Composiciones y métodos para prevenir el cáncer con cupredoxinas. | |
| UA100007C2 (ru) | Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит | |
| ECSP11011297A (es) | Proteinas ligadoras il-17 | |
| WO2009109927A3 (en) | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | |
| MY146969A (en) | Dpp iv inhibitor formulations | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| MX2009010034A (es) | Pirimidodiazepinas sustituidas utiles inhibidores de la plk1. | |
| MY153198A (en) | Inhibitors of protein aggregation | |
| WO2009038689A3 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
| PT1991680E (pt) | Sistema para a expressão de componentes ortogonais de tradução em células hospedeiras eubacterianas | |
| MX2009005455A (es) | (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano. | |
| UA100840C2 (ru) | Композиция для лечения вирусного гепатита | |
| WO2008030273A3 (en) | Compositions and methods for diagnosis and treatment of type 2 diabetes | |
| EP3718560A3 (en) | Cyclin dependent kinase inhibitors and methods of use | |
| MX2009006594A (es) | Formulaciones de ph regulado y estables que contienen polipeptidos. | |
| MY161991A (en) | Proteasome inhibitors | |
| MX2009005460A (es) | (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano. | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| MX2007016322A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
| CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
| TW200735890A (en) | Compositions and methods for increasing insulin sensitivity | |
| WO2008011071A3 (en) | Interactions of hedgehog and liver x receptor signaling pathways | |
| GB0718957D0 (en) | Optical imaging agents | |
| MX2009007337A (es) | Indazoles sustituidos con 5-piridinona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |